This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Explore the best credit card rewards program that suits your lifestyle and spending habits. Maximize your benefits and earn rewards with ease.
15,506 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
If I had just $500 to invest in the AI wave, I’d narrow it to one strong option. This guide explains why and how to m...
Pre-marketing for homes, dubbed coming soon listings, has moved from niche tests to a nationwide driver of housing de...
JPMorgan’s Dividend Leaders ETF shows a surprising income mismatch, posting a 1.59% yield while Treasuries offer more...
California Governor Gavin Newsom backs renaming César Chavez Day as Farmworkers Day, igniting a statewide debate over...
With rate-cut bets disappearing, traders pivot to potential rate hikes and Bitcoin’s role as a long-term hedge agains...
When a major broker raises its bets on a fintech-insurer, investors take notice. This article breaks down the upgrade...
Bitcoin surges in early trading after news that Iran postponed strikes. The move highlights how geopolitical headline...
A pullback in AbbVie has some investors asking if the stock looks like a bargain. This guide explains why that view m...
Medicare Part B premiums rose to $202.90 per month in 2026, eroding a portion of the Social Security COLA for million...
Delek US shares jumped as crude and refining margins strengthened. This article breaks down the drivers, the risks, a...
Three top clean energy ETFs have surged more than 50% over the past year, offering divergent paths to the green trans...